U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07055958) titled 'Effect of Metformin as Add-on Therapy in Levodopa Treated Parkinson's Disease Patients' on May 30.
Brief Summary: The goal of this clinical trial is to learn that metformin has effect on motor aspects of daily living and oxidative stress in levodopa treated Parkinson disease patients. Researcher will compare drug metformin to a placebo. Participants will take metformin or placebo for 8 weeks.
Study Start Date: Dec. 29, 2024
Study Type: INTERVENTIONAL
Condition:
Parkinson Disease
Intervention:
DRUG: Metformin
Metformin's chemical name is 1,1-Dimethylbiguanide, a molecular formula of C4H11N5. Beyond its well established antihyp...